In the peripheral blood of patients with HCC, the EpCAM-based identification of circulating tumor cells (CTCs) is considered to be an indicator of portal vein thrombosis, early recurrence risk, and high metastatic potential [33, 45, 54–57]. The gene discussed is EPCAM; the disease is hepatocellular carcinoma.